Ken Griffin's position in Novo Nordisk is currently worth $239 Million. That's 0.23% of their equity portfolio (87th largest holding). The first Novo Nordisk trade was made in Q3 2014. Since then Ken Griffin bought shares 59 more times and sold shares on 50 occasions. The investor's estimated purchase price is $342 Million, resulting in a loss of 30%.